UNC among 10 U.S. medical centers tapped to study living donor liver transplants

October 09, 2002

CHAPEL HILL -- The National Institutes of Health has designated the University of North Carolina at Chapel Hill one of 10 medical centers nationwide to participate in the Adult to Adult Living Donor Liver Transplant Cohort Study.

The seven-year project will investigate the experience of patients eligible for living donor liver transplantation, focusing on factors influencing outcomes for donors and recipients. Researchers will compare outcomes of this procedure with those for patients who receive livers from cadavers.

Because of the shortage of donor livers, many patients with liver disease die while awaiting an organ for transplantation. In 2001, about 17,000 patients waited for donated livers, but only 4,673 cadeveric organs were actually donated that year.

"Liver transplantation is the only definitive therapy for end-stage liver disease. Due to the huge discrepancy between the number of cadaveric organs available for standard transplantation and patient need, centers around the world are trying to expand the donor pool by using livers from live donors. UNC has been a pioneer in this effort," said Dr. Roshan Shrestha, associate professor of medicine at the School of Medicine and medical director of the liver transplantation program. Shrestha is also principal investigator of the UNC study site.

In living donor liver transplants, a living healthy donor, usually a relative of the patient, donates a section of liver to the recipient. The liver is a large segmented organ that can potentially be split without harm to the donor and with benefit to the recipient. Unlike most organs, the liver can regenerate itself. The donor's remaining liver grows to its original size within weeks. Likewise, the donated lobe will also grow in the recipient's body.

For children in need of liver transplantation, the success of living donor transplantation from an adult made it an accepted medical option. Adults in need of liver transplantation require a larger segment, as much as half or more of the donor's liver. This requires a more extensive and complex surgery, with potentially greater risks for donor and recipient.

The procedure has evolved so rapidly that more than half of living donor transplants performed to date have occurred since 2000, according to the National Institute of Diabetes & Digestive & Kidney Diseases. Evaluation of donors and surgical procedures varies from one transplant center to another. The institute has pointed out that although the large majority of living donor liver transplants have been successful, data are few to inform potential donors about risks. Post-surgical problems for donors can include infection, pneumonia and leaking bile, which can require further surgery.

"Among many important questions this multi-center study will explore, UNC proposes we study drug metabolism in the regenerating livers of donors and recipients. We are also proposing studies on short- and long-term outcomes for donors following donation surgery for living donor liver transplantation," Shrestha said.

UNC began its live donor liver transplant program in October 1996. Today, the UNC Center for Liver Diseases and Transplantation provides highly specialized care for liver diseases for residents of North Carolina and surrounding regions. In addition to its commitment to patient care, the UNC liver program is dedicated to studying novel therapies for viral hepatitis, other chronic liver diseases and transplantation.

"It's gratifying that living donor liver transplantation is a priority issue for NIH, one that requires answers to important questions on benefits and risks," said Dr. Jeffrey H. Fair, director of abdominal transplantation at UNC and co-principal investigator. "Our transplant program at UNC has been among the leaders in the field and will continue to evolve and change as the field evolves. We are very honored to be a part of this new study."

Along with UNC, participating medical centers include the University of California at Los Angeles, the University of California at San Francisco, the University of Colorado at Denver, Northwestern University, Columbia University, the University of Pennsylvania, the University of Virginia, Virginia Commonwealth University and the University of Michigan.
Note: Contact Shrestha at 919-966-2516 (choose option "0") or r_shrestha@med.unc.edu. Contact Fair at 919-966-8008 or jeff_fair@med.unc.edu.

School of Medicine contact: Les Lang at 919-843-9687 or llang@med.unc.edu

University of North Carolina Health Care

Related Liver Transplantation Articles from Brightsurf:

Study reveals improving survival rates after liver transplantation in the UK
In the past two decades, death rates after liver transplantation have dropped by more than half in the UK, according to a recent analysis of almost 10,000 liver transplant recipients published in BJS (British Journal of Surgery).

Advancing transplantation: Hepatitis C-infected organs safe for transplantation when followed by antiviral treatment
Twenty patients at Penn Medicine have been cured of the hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease, according to a study published today in Annals of Internal Medicine.

US study reports dramatic reduction in likelihood of liver transplantation in patients with hepatoce
ILC 2018: Although hepatocellular carcinoma is now the leading indication for liver transplantation in the USA, the probability of patients receiving a transplant has declined significantly in recent years.

HCV-related liver transplantation and post-transplant survival rates in Europe have improved rapidly in the era of direct-acting antiviral drugs
HCV-related liver transplantation and post-transplant survival rates in Europe have improved rapidly in the era of direct-acting antiviral drugs.

Alcoholic liver disease replaces hepatitis C infection as the leading cause of liver transplantation in patients without hepatocellular carcinoma in the USA
Two independent US studies confirm that, from 2016 onwards, alcoholic liver disease has led to more liver transplants than hepatitis C infection in patients without hepatocellular carcinoma (HCC).

The Journal of Heart and Lung Transplantation: 50 years of heart transplantation progress
This month marks the 50th anniversary of the world's first human heart transplant performed at Groote Schuur Hospital in Cape Town by South African surgeon, Christiaan Barnard.

Researchers develop new technique to model transplantation of the human liver
A novel technology developed by researchers at the Massachusetts General Hospital enables the model-ing of human liver transplantation in an experimental setting.

New method creates liver bioscaffolds with intact ECM for reseeding and transplantation
Researchers have reported a method for successfully removing the cellular material from whole human livers while retaining the organ's three-dimensional structure and extracellular matrix (ECM) components.

Routine hospital tool found to predict poor outcomes after liver transplantation
A routinely used hospital tool can predict which liver transplant recipients are more likely to do poorly after surgery, according to a study led by Cedars-Sinai.

Critically ill children can still undergo liver transplantation and survive
Advancements in critical care make it possible for even the sickest children to successfully undergo liver transplantation.

Read More: Liver Transplantation News and Liver Transplantation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.